UNMA
Unum Group 6.250% JR NT58 [UNMA] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
UNMA Stock Summary
Top UNMA Correlated Resources
UNMA
Top 10 Correlated ETFs
UNMA
Top 10 Correlated Stocks
UNMA
In the News
UNMA Financial details
Company Rating
Buy
Market Cap
9.64B
Income
1.28B
Revenue
12.39B
Book val./share
49.56
Cash/share
198.18
Dividend
1.56
Dividend %
6.25%
Employees
10.81K
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
3.98
Forward P/E
-
PEG
-5.81
P/S
0.73
P/B
0.51
P/C
0.12
P/FCF
10.14
Quick Ratio
-
Current Ratio
-
Debt / Equity
0.36
LT Debt / Equity
0.36
-
-
EPS (TTM)
6.53
EPS next Y
-
EPS next Q
-
EPS this Y
-6.85%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
4.46%
Revenue last 5Y
0.64%
Revenue Q/Q
1.7%
EPS Q/Q
65.05%
-
-
-
-
SMA20
-4%
SMA50
-4%
SMA100
-
Inst Own
0%
Inst Trans
1%
ROA
4549%
ROE
13%
ROC
-7.9%
Gross Margin
142%
Oper. Margin
16%
Profit Margin
10%
Payout
16%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
21.49-25.45
52W High
-2.2%
52W Low
+16.43%
RSI
29
Rel Volume
0.34
Avg Volume
13.64K
Volume
4.68K
Perf Week
-1.77%
Perf Month
-1.17%
Perf Quarter
10.63%
Perf Half Y
10.43%
-
-
-
-
Beta
0.405344
-
-
Volatility
0.1%, 0.29%
Prev Close
0.74%
Price
24.45
Change
0.49%
UNMA Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 57.21 | 64.63 | 58.82 | 59.76 | 62.98 | |
| Net income per share | 5.25 | 3.89 | 4.8 | 7.01 | 6.53 | |
| Operating cash flow per share | 8.3 | 2.93 | 6.79 | 7.07 | 6.12 | |
| Free cash flow per share | 7.58 | 2.35 | 6.25 | 6.56 | 5.43 | |
| Cash per share | 6.57 | 8.19 | 7.16 | 7.55 | 196.23 | |
| Book value per share | 47.51 | 53.38 | 55.9 | 45.84 | 49.08 | |
| Tangible book value per share | 45.41 | 326.2 | 322.13 | 43.79 | 302.1 | |
| Share holders equity per share | 47.51 | 53.38 | 55.9 | 45.84 | 49.08 | |
| Interest debt per share | 18.61 | 17.48 | 17.87 | 18.04 | 18.53 | |
| Market cap | 6.12B | 4.67B | 5.02B | 8.23B | 8.89B | |
| Enterprise value | 9.36B | 7.82B | 8.39B | 11.54B | 12.18B | |
| P/E ratio | 5.56 | 5.89 | 5.12 | 5.85 | 6.93 | |
| Price to sales ratio | 0.51 | 0.35 | 0.42 | 0.69 | 0.72 | |
| POCF ratio | 3.51 | 7.82 | 3.62 | 5.8 | 7.39 | |
| PFCF ratio | 3.84 | 9.76 | 3.93 | 6.25 | 8.33 | |
| P/B Ratio | 0.61 | 0.43 | 0.44 | 0.9 | 0.92 | |
| PTB ratio | 0.61 | 0.43 | 0.44 | 0.9 | 0.92 | |
| EV to sales | 0.78 | 0.59 | 0.7 | 0.96 | 0.98 | |
| Enterprise value over EBITDA | 7.36 | 9.16 | 8.92 | 5.98 | 7.42 | |
| EV to operating cash flow | 5.37 | 13.09 | 6.04 | 8.14 | 10.12 | |
| EV to free cash flow | 5.88 | 16.35 | 6.57 | 8.77 | 11.4 | |
| Earnings yield | 0.18 | 0.17 | 0.2 | 0.17 | 0.14 | |
| Free cash flow yield | 0.26 | 0.1 | 0.25 | 0.16 | 0.12 | |
| Debt to equity | 0.37 | 0.31 | 0.3 | 0.37 | 0.36 | |
| Debt to assets | 0.06 | 0.05 | 0.05 | 0.06 | 0.05 | |
| Net debt to EBITDA | 2.55 | 3.69 | 3.58 | 1.71 | 2 | |
| Current ratio | 19.42 | -1.22 | -1.21 | 15.77 | -0.1 | |
| Interest coverage | 6.54 | 3.93 | 4.43 | 9.65 | 8.42 | |
| Income quality | 1.58 | 0.75 | 1.68 | 1.08 | 0.94 | |
| Dividend Yield | 0.04 | 0.05 | 0.05 | 0.03 | 0.03 | |
| Payout ratio | 0.21 | 0.29 | 0.24 | 0.18 | 0.22 | |
| Sales general and administrative to revenue | 0.07 | 0.07 | 0.08 | 0.09 | 0.09 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0 | 0.01 | 0.01 | 0.01 | |
| Capex to operating cash flow | -0.09 | -0.2 | -0.08 | -0.07 | -0.11 | |
| Capex to revenue | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
| Capex to depreciation | -1.37 | -1.05 | -0.92 | -0.92 | -1.24 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 74.89 | 68.39 | 77.73 | 85.05 | 84.9 | |
| ROIC | 0.07 | 0.04 | 0.04 | 0.12 | 0.1 | |
| Return on tangible assets | 0.02 | 0.01 | 0.01 | 0.02 | 0.02 | |
| Graham Net | -253.36 | 23.15 | 23.05 | -209.06 | 84.32 | |
| Working capital | 7.36B | 25.38B | 25.42B | 2.85B | 10.42B | |
| Tangible asset value | 9.61B | 66.51B | 65.79B | 8.85B | 59.41B | |
| Net current asset value | -49.29B | 10.16B | 10B | -49.2B | -2.46B | |
| Invested capital | 0.37 | 0.31 | 0.3 | 0.37 | 0.36 | |
| Average receivables | 6.33B | 9.32B | 12.35B | 12.07B | 11.18B | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | -2.26B | -4.64B | -4.57B | -2.19B | -26.57B | |
| Days sales outstanding | 194.19 | 339.93 | 377.92 | 356.16 | 313.91 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | -7.5K | 0 | -42.91K | |
| Receivables turnover | 1.88 | 1.07 | 0.97 | 1.02 | 1.16 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | -0.05 | 0 | -0.01 | |
| ROE | 0.11 | 0.07 | 0.09 | 0.15 | 0.13 | |
| Capex per share | -0.72 | -0.58 | -0.54 | -0.51 | -0.69 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 15.12 | 15.33 | 15.78 | 15.77 | 16.15 | |
| Net income per share | 1.41 | 1.81 | 1.99 | 1.03 | 1.7 | |
| Operating cash flow per share | 1.8 | 0.76 | 1.59 | 2.01 | 1.76 | |
| Free cash flow per share | 1.64 | 0.61 | 1.45 | 1.85 | 1.53 | |
| Cash per share | 7.61 | 7.3 | 188.33 | 8.43 | 198.18 | |
| Book value per share | 46.26 | 46.68 | 46.89 | 49.05 | 49.56 | |
| Tangible book value per share | 44.19 | 43.16 | 43.34 | 45.5 | 305.1 | |
| Share holders equity per share | 46.26 | 46.68 | 46.89 | 49.05 | 49.56 | |
| Interest debt per share | 17.5 | 17.57 | 17.66 | 17.75 | 17.97 | |
| Market cap | 8.16B | 7.84B | 9.41B | 9.65B | 8.81B | |
| Enterprise value | 11.47B | 11.14B | 12.73B | 12.91B | 12.09B | |
| P/E ratio | 7.29 | 5.47 | 5.98 | 11.94 | 6.66 | |
| Price to sales ratio | 2.71 | 2.58 | 3.02 | 3.12 | 2.8 | |
| POCF ratio | 22.86 | 52.04 | 29.99 | 24.41 | 25.63 | |
| PFCF ratio | 25.06 | 64.5 | 32.84 | 26.62 | 29.57 | |
| P/B Ratio | 0.89 | 0.85 | 1.02 | 1 | 0.91 | |
| PTB ratio | 0.89 | 0.85 | 1.02 | 1 | 0.91 | |
| EV to sales | 3.82 | 3.67 | 4.09 | 4.18 | 3.84 | |
| Enterprise value over EBITDA | 26.36 | 22.32 | 29.79 | 49.34 | 30.45 | |
| EV to operating cash flow | 32.13 | 74 | 40.59 | 32.68 | 35.2 | |
| EV to free cash flow | 35.23 | 91.73 | 44.44 | 35.64 | 40.6 | |
| Earnings yield | 0.03 | 0.05 | 0.04 | 0.02 | 0.04 | |
| Free cash flow yield | 0.04 | 0.02 | 0.03 | 0.04 | 0.03 | |
| Debt to equity | 0.37 | 0.37 | 0.37 | 0.36 | 0.36 | |
| Debt to assets | 0.06 | 0.05 | 0.06 | 0.06 | 0.05 | |
| Net debt to EBITDA | 7.61 | 6.62 | 7.78 | 12.48 | 8.27 | |
| Current ratio | 15.77 | 52.07 | 265.73 | 44.64 | -0.1 | |
| Interest coverage | 8.65 | 9.83 | 8.74 | 5.38 | -23.61 | |
| Income quality | 1.28 | 0.42 | 0.8 | 1.96 | 1.04 | |
| Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Payout ratio | 0.24 | 0.19 | 0.17 | 0.35 | 0.22 | |
| Sales general and administrative to revenue | 0.1 | 0.09 | 0.09 | 0.1 | 0.09 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Capex to operating cash flow | -0.09 | -0.19 | -0.09 | -0.08 | -0.13 | |
| Capex to revenue | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
| Capex to depreciation | -1.16 | -1.09 | -1.05 | -1.17 | -1.64 | |
| Stock based compensation to revenue | 0.02 | 0 | 0 | 0 | 0 | |
| Graham number | 38.26 | 43.58 | 45.85 | 33.72 | 43.51 | |
| ROIC | 0.02 | 0.03 | 0.03 | 0.02 | -0.07 | |
| Return on tangible assets | 0 | 0.01 | 0.01 | 0 | 0.01 | |
| Graham Net | -210.98 | -231.01 | -49.56 | -220.9 | 85.16 | |
| Working capital | 2.85B | 12.39B | 47.94B | 11.75B | 10.42B | |
| Tangible asset value | 8.85B | 8.9B | 8.9B | 9.27B | 59.41B | |
| Net current asset value | -49.2B | -40.54B | -4.53B | -38.32B | -2.46B | |
| Invested capital | 0.37 | 0.37 | 0.37 | 0.36 | 0.36 | |
| Average receivables | 11.73B | 11.44B | 11.09B | 10.68B | 10.51B | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | -2.33B | -2.42B | -4.91B | -4.89B | -28.97B | |
| Days sales outstanding | 350.36 | 331.58 | 317.77 | 301.59 | 304.82 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | -6.65K | -3.49K | -2.31K | -68.02K | |
| Receivables turnover | 0.26 | 0.27 | 0.28 | 0.3 | 0.3 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | -0.01 | -0.03 | -0.04 | 0 | |
| ROE | 0.03 | 0.04 | 0.04 | 0.02 | 0.03 | |
| Capex per share | -0.16 | -0.15 | -0.14 | -0.17 | -0.23 |
UNMA Frequently Asked Questions
What is Unum Group 6.250% JR NT58 stock symbol ?
Unum Group 6.250% JR NT58 is a US stock and trading under the symbol UNMA
What is Unum Group 6.250% JR NT58 stock quote today ?
Unum Group 6.250% JR NT58 stock price is $24.45 today.
Is Unum Group 6.250% JR NT58 stock public?
Yes, Unum Group 6.250% JR NT58 is a publicly traded company.
Company Profile
- Volume Average 13.64K
- Market Capitalization 9.64B
- Employee 10.81K
- CEO None
- Headquarters Chattanooga,US
- IPO Date 2018-06-19
-
Website
http://www.unum.com 
Unum Group engages in the provision of financial protection benefits. Its services include disability, life, accident, critical illness, dental, vision, and other related services. It operates through the following segments: Unum US, Unum International, Colonial Life, Closed Block, and Corporate. The Unum US segment focuses on group disability, group life and accidental death and dismemberment products, and supplemental and voluntary lines of business. The Unum International segment engages in the operations of the UK business, which includes insurance for group long-term disability, group life, and supplemental lines of business that include dental, individual disability, and critical illness products. The Colonial Life segment includes insurance for accident, sickness, disability products, life products, and cancer and critical illness products. The Closed Block segment consists of individual disability, group and individual long-term care, and other insurance products no longer actively marketed. The Corporate segment refers to investment income on corporate assets and other corporate income and expenses not allocated to a line of business. The company was founded in 1848 and is headquartered in Chattanooga, TN.
